PATENT CLAIM ANALYSIS

Application Number: 15773463
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["514", "218000"]

Abstract:
The present invention relates to methods of treating a tumor or treating cancer in a subject having a p53 DNA contact mutation that involve administering, to the subject, a ROCK inhibitor. Also disclosed is a method of identifying a subject as a candidate for such treatment.

Claim (Index 17):
The method according to  claim 16 , wherein the ROCK inhibitor and the tankyrase inhibitor are each administered at a dose sufficient in their combination to treat the subject for cancer but not sufficient for either the ROCK inhibitor or the tankyrase inhibitor alone to treat the subject for cancer.

Metadata:
- Claim Count in Document: 72.0
- Percentile: 93.0
- Lexical Diversity: 1.35135
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15767156', '15031754', '15762993', '14381119', '12731374']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7854954185732184
- 35 USC 102 Novelty (BERT): 0.5254150029498168
- Combined Prediction Score: 0.7594873770108783
- Mean Citation Score: 291.887924
- Max Citation Score: 317.71756
- Similarity Product: 197.98275936225173

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test